Wellington Regional Medical Center is located at the intersection of Forest Hill Blvd. and State Road 7 in Wellington. [Photo by Wellington Regional Medical Center]
Wellington Regional Medical Center now offers Aquablation therapy using the state-of-the-art HYDROS Robotic System to treat benign prostatic hyperplasia, known as an enlarged prostate.
This AI-powered, robot-assisted therapy provides significant and durable relief from BPH symptoms while preserving sexual function and continence, regardless of prostate size or shape.
BPH affects millions of men, particularly as they age, causing difficulties such as frequent nighttime urination, urgency and incomplete bladder emptying. Untreated BPH can lead to permanent bladder or kidney damage, bladder stones, and incontinence. Half of men ages 51 to 60 experience BPH, and 99% report a negative impact on their quality of life.
The risks of traditional surgical interventions include impacts on sexual function and continence. Aquablation therapy, however, is minimally invasive and prioritizes safety and efficacy.
A Technological Leap
Aquablation therapy uses real-time, ultrasound-guided, robotic-assisted waterjet technology. Surgeons can develop personalized treatment plans tailored to each patient’s anatomy to ensure the precise removal of problematic prostate tissue while safeguarding critical structures.
The HYDROS Robotic System further enhances the therapy with FirstAssist AI treatment planning, advanced imaging and robotic resection. Drawing on insights from over 50,000 procedures, HYDROS improves workflow efficiency and consistency.
“Our goal is to help men reclaim their quality of life,” said Pam Tahan, the CEO of Wellington Regional Medical Center. “Aquablation therapy allows patients to achieve relief from BPH symptoms without compromising sexual function or continence — a balance that traditional treatments have struggled to deliver.”
Wellington Regional Medical Center’s adoption of the HYDROS Robotic System underscores its commitment to the latest medical technology.
Aquablation therapy is supported by five years of clinical data demonstrating durable symptom relief and preservation of sexual function. The system integrates ultrasound imaging and digital cystoscopy to give surgeons a multidimensional view of the prostate. This precise visualization enables custom treatment plans executed by a heat-free waterjet.
